Garching, Germany

Isotopen Technologien Munchen Ag


USPTO Granted Patents = 4

% Expired Patents = 100.0


Forward Citations = 36

Loading Chart...
Loading Chart...

9 inventors (with patents filed for the assignee):

goldMedal Michael Schilp (4 out of 11 patents)

silverMedal Oliver Buck (4 out of 6 patents)

bronzeMedal Tuomo Nikula (2 out of 10 patents)

4.  Mark Harfensteller (1 out of 7 patents)

5.  Nikula Tuomo (1 out of 1 patent)

6.  Christoph Ehlers (1 out of 1 patent)

7.  Julian Bernd Sonnenhol (1 out of 1 patent)

8.  Andreas Eursch (1 out of 1 patent)

9.  Lisa Maria Ehrenfried (1 out of 1 patent)

10.  Richard Henkelmann (4 patents)

11.  Andreas Türler (0 patent)

12.  Raffaella Perego (0 patent)


4 patents:

Company Overview
Isotopen Technologien Munchen Ag is a leading radiopharmaceutical company that specializes in the development, production, and global distribution of innovative diagnostic and therapeutic radiopharmaceuticals. With a strong focus on research and development, ITM is dedicated to advancing precision medicine and improving patient outcomes in the field of nuclear medicine. Through collaborations with leading healthcare providers and academic institutions, ITM is at the forefront of developing cutting-edge solutions for cancer therapy and other medical applications.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#7 in Garching

#7,037 in Germany

Garching, DE
Garching, Germany
Forward Citations = 36

9 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Isotopen Technologien Munchen Ag. Retrieved from https://idiyas.com/company/isotopen-technologien-munchen-ag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…